Fennec Pharmaceuticals Reports Third Quarter 2026 Financial Results and Provides Business Update Read more about Fennec Pharmaceuticals Reports Third Quarter 2026 Financial Results and Provides Business Update
Fennec Pharmaceuticals to Report Third Quarter 2026 Financial Results on November 12, 2026 Read more about Fennec Pharmaceuticals to Report Third Quarter 2026 Financial Results on November 12, 2026
Fennec Pharmaceuticals Announces Oral Presentation of Detailed Results from Investigator-Initiated Phase 2 STS-J01 Clinical Study of Pedmark® in Japan at SIOP 2026 Read more about Fennec Pharmaceuticals Announces Oral Presentation of Detailed Results from Investigator-Initiated Phase 2 STS-J01 Clinical Study of Pedmark® in Japan at SIOP 2026
Fennec Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update Read more about Fennec Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update
Fennec Pharmaceuticals to Report Second Quarter 2026 Financial Results on August 11, 2026 Read more about Fennec Pharmaceuticals to Report Second Quarter 2026 Financial Results on August 11, 2026
Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) Read more about Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Fennec Announces Results of Annual Meeting Read more about Fennec Announces Results of Annual Meeting
Fennec Pharmaceuticals Announces New Research Supporting Integration and Use of PEDMARK® at the 2026 ASCO Annual Meeting Read more about Fennec Pharmaceuticals Announces New Research Supporting Integration and Use of PEDMARK® at the 2026 ASCO Annual Meeting
Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Read more about Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Fennec Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Business Update Read more about Fennec Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Business Update
